Featured Research

from universities, journals, and other organizations

Model to study human response to bacteria that cause peptic ulcers developed

Date:
September 25, 2013
Source:
Virginia Tech (Virginia Polytechnic Institute and State University)
Summary:
Researchers have developed a model that helps scientists and clinicians understand that complex interactions of a type of bacteria that is the leading cause of peptic ulcers. The discovery may inform changes in the ways doctors treat patients.

Similar anatomical properties between the stomach of humans and pigs may facilitate study of H. pylori-associated disease. Virginia Bioinformatics Institute researchers have demonstrated that H. pylori (arrow) is found in the inner lining of the stomach and and near aggregates of immune cells. The picture insert shows the typically spindle-shaped H. pylori magnified 1,000 times.
Credit: Image courtesy of Virginia Tech (Virginia Polytechnic Institute and State University)

Researchers at the Virginia Bioinformatics Institute at Virginia Tech have developed a new large animal model to study how the immune system interacts with the stomach bacterium Helicobacter pylori, the leading cause of peptic ulcer disease.

The discovery in the October edition of the journal Infection and Immunity may inform changes in the ways doctors treat patients. An estimated 4 million Americans have sores in the stomach lining known as peptic ulcers, according to the American Gastroenterological Association.

Although the bacterium is found in more than half the world’s population, most people do not develop diseases. However, some experience chronic inflammation of the stomach, or gastritis, which can lead to the development of ulcers or cancer.

In addition to its role as a pathogen, the bacteria have beneficial effects, preventing certain chronic inflammatory and metabolic diseases, including Type 2 diabetes, and obesity.

When bacteria reside within host cells, the immune system typically recruits a type of white blood cell called T cells — in this case, CD8+ cytotoxic T cells — to destroy the infected cells.

However, the researchers found that these cells may contribute to tissue damage.

In patients with H. pylori-associated gastritis, higher numbers of cytotoxic T cells are present, indicating that these cells may contribute to the development of gastric lesions.

To study immune responses in H. pylori-mediated disease, researchers at the Virginia Bioinformatics Institute’s Nutritional Immunology and Molecular Medicine Laboratory developed a pig model that closely mimics the human gastric environment. When pigs were infected with H. pylori, the researchers observed an increase in another type of immune cells called pro-inflammatory CD4+ T helper cells, followed by an increase in CD8+ cytotoxic T cells, according to the study.

Scientists did not observe an increase in CD8+ T cells in mouse and gerbil models of H. pylori infection. However, the rise of the cells in pigs mirrors the recent findings in human clinical studies.

“Pigs have greater anatomic, physiologic and immunologic similarities to humans than mice, the main animal model used in biomedical research," said Raquel Hontecillas, co-director of the Nutritional Immunology and Molecular Medicine Laboratory and the Center for Modeling Immunity to Enteric Pathogens. "The results from our new pig model closely mimic what has been reported in clinical settings, which will allow us to comprehensively and systematically investigate human immune responses to H. pylori.”

The discovery will help scientists better understand the complex interactions of H. pylori and its host.

Researchers within the Center for Modeling Immunity to Enteric Pathogens are using results from the pig model and other experimental data to develop a computational model of H. pylori infection. Such modeling efforts aim to develop faster, more efficient ways to predict initiation, progression and outcomes of infection.

The Center for Modeling Immunity to Enteric Pathogens is funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, under Contract No. HHSN272201000056C. PI: Josep Bassaganya-Riera.


Story Source:

The above story is based on materials provided by Virginia Tech (Virginia Polytechnic Institute and State University). Note: Materials may be edited for content and length.


Journal Reference:

  1. B. Kronsteiner, J. Bassaganya-Riera, C. Philipson, M. Viladomiu, A. Carbo, M. Pedragosa, S. Vento, R. Hontecillas. Helicobacter pylori Infection in a Pig Model Is Dominated by Th1 and Cytotoxic CD8 T Cell Responses. Infection and Immunity, 2013; 81 (10): 3803 DOI: 10.1128/IAI.00660-13

Cite This Page:

Virginia Tech (Virginia Polytechnic Institute and State University). "Model to study human response to bacteria that cause peptic ulcers developed." ScienceDaily. ScienceDaily, 25 September 2013. <www.sciencedaily.com/releases/2013/09/130925130300.htm>.
Virginia Tech (Virginia Polytechnic Institute and State University). (2013, September 25). Model to study human response to bacteria that cause peptic ulcers developed. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2013/09/130925130300.htm
Virginia Tech (Virginia Polytechnic Institute and State University). "Model to study human response to bacteria that cause peptic ulcers developed." ScienceDaily. www.sciencedaily.com/releases/2013/09/130925130300.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) — An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) — Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) — Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) — It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins